Research material and lot documents
Pinealon and Epithalon are different peptides: Pinealon has the three-residue sequence Glu-Asp-Arg (EDR), while Epithalon has the four-residue sequence Ala-Glu-Asp-Gly (AEDG) (Sources: Pinealon sequence source, Epitalon reference record).
The catalog identifies separate laboratory materials: Pinealon research listing at Curo and Epithalon research listing at Curo.
For the Pinealon study record, open Pinealon EDR identity and research record.
No. Pinealon's Glu-Asp-Arg sequence contains three residues; Epithalon's Ala-Glu-Asp-Gly sequence contains four. EDR and AEDG identify these different sequences (Sources: Pinealon sequence source, Epitalon sequence record).
Sequence: Glu-Asp-Arg (Source: Primary sequence source).
Notation: EDR; PubChem also lists E-D-R (Sources: Pinealon paper, PubChem synonyms).
Residue count: 3 (tripeptide) (Source: Sequence source).
Formula: C15H26N6O8 (Source: PubChem reference properties).
Reference molecular weight: 418.40 g/mol (Source: PubChem reference properties).
PubChem CID: 10273502 (Source: Pinealon compound record).
Cited experimental settings: cerebellar granule cells, neutrophils and PC12 cells; rat offspring after prenatal hyperhomocysteinemia and isolated cerebellar neurons; and an Alzheimer's mouse model involving EDR and KED (Sources: 2011 cell study, 2012 rat study, 2021 EDR and KED mouse study).
Sequence: Ala-Glu-Asp-Gly (Source: Epitalon reference record).
Notation: AEDG (Source: Epitalon reference record).
Residue count: 4 (tetrapeptide) (Source: Sequence record).
Formula: C14H22N4O9 (Source: PubChem reference properties).
Reference molecular weight: 390.35 g/mol (Source: PubChem reference properties).
PubChem CID: 219042 (Source: Epitalon compound record).
Cited experimental setting: telomerase-negative human fetal fibroblast culture (Source: 2003 Epithalon fibroblast study).
The reference properties for EDR and AEDG are recorded separately in PubChem (Sources: Pinealon PubChem record, Epitalon PubChem record).
The 2011 Pinealon paper examined ROS accumulation, necrotic cell death and ERK1/2 activation in cerebellar granule cells, neutrophils and PC12 cells. The 2012 paper examined spatial orientation and learning in rat offspring after prenatal hyperhomocysteinemia, plus ROS accumulation and necrotic cell counts in isolated cerebellar neurons (Sources: 2011 Pinealon cell study, 2012 Pinealon rat study).
The 2021 paper studied both EDR and KED in an Alzheimer's mouse model, focusing on dendritic-spine morphology and possible epigenetic mechanisms explored through molecular modelling (Source: 2021 EDR and KED mouse study).
The cited 2003 Epithalon paper measured telomerase-related changes in telomerase-negative human fetal fibroblast culture. Its author record lists V. Kh. Khavinson with the St. Petersburg Institute of Bioregulation and Gerontology (Source: 2003 Epithalon study and affiliation record).
The authors reported that Epithalon induced expression of the catalytic subunit of telomerase, telomerase enzymatic activity and telomere elongation in telomerase-negative human fetal fibroblast culture (Source: 2003 Epithalon fibroblast study).
The authors proposed reactivation of the telomerase gene as a possible explanation for these changes (Source: 2003 Epithalon mechanism hypothesis).
The Pinealon papers and the Epithalon fibroblast paper address different experimental questions: oxidative-stress responses and neuronal measures for Pinealon, and telomerase activity and telomere length for Epithalon (Sources: Pinealon cell study, Pinealon rat study, EDR and KED mouse study, Epithalon fibroblast study).
For supplier-authored reading, open Curo's Epithalon research article.
PubChem lists Epitalon, Epithalon and Epithalone as synonyms for CID 219042 (Source: PubChem alias record). FDA's substance record for UNII O65P17785G also maps Epithalon to Epitalon (Source: FDA substance identity record).
The cited cell and animal experiments, including Epithalon's human-derived fibroblast culture, do not establish efficacy, safety or superiority of either peptide in people (Sources: Pinealon cell study, Pinealon rat study, EDR and KED mouse study, Epithalon fibroblast study).
The FDA record states that UNII availability does not imply regulatory review or approval (Source: FDA substance-record qualification).
Use the listing for the intended compound: Pinealon research listing at Curo or Epithalon research listing at Curo. Each 10mg label describes a catalog pack amount.
For the report library, Match a Curo lot to its report. Check each compound name and lot identifier against its own material listing and report.
No. Pinealon identifies Glu-Asp-Arg (EDR), while Epithalon identifies Ala-Glu-Asp-Gly (AEDG). Epitalon is an alias of Epithalon (Sources: Pinealon sequence source, Epitalon sequence and alias record).
No. The 2003 study measured telomerase and telomere changes in fibroblast culture; it did not test Epithalon in people (Source: 2003 Epithalon experimental-setting source).
No. PubChem CIDs 10273502 and 219042 describe the reference compounds and do not certify a supplier lot (Sources: Pinealon compound record, Epitalon compound record).